Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EQV Ventures Acquisition | EQV | Nov 26, 2024 | 9.94 | 0.00 |
Erasca | ERAS | Nov 26, 2024 | 2.78 | +0.72 |
Erayak Power Solution Group A | RAYA | Nov 26, 2024 | 1.18 | +2.61 |
Ericsson B ADR | ERIC | Nov 26, 2024 | 8.20 | +0.49 |
Erie Indemnity A | ERIE | Nov 26, 2024 | 438.48 | +1.66 |
Ermenegildo Zegna N.V. | ZGN | Nov 26, 2024 | 7.82 | -1.88 |
Ero Copper | ERO | Nov 26, 2024 | 15.16 | -3.62 |
ESAB | ESAB | Nov 26, 2024 | 128.72 | -0.31 |
Escalade | ESCA | Nov 26, 2024 | 14.85 | -4.56 |
Esco Technologies | ESE | Nov 26, 2024 | 148.89 | -1.64 |
ESGL | ESGL | Nov 26, 2024 | 1.37 | -20.81 |
ESH Acquisition | ESHA | Nov 26, 2024 | 10.68 | +0.19 |
Eshallgo | EHGO | Nov 26, 2024 | 3.95 | +0.77 |
Esperion Therapeutics | ESPR | Nov 26, 2024 | 2.57 | 0.00 |
Espey Mfg & Electronics | ESP | Nov 26, 2024 | 30.39 | +5.45 |
Esquire Financial | ESQ | Nov 26, 2024 | 77.24 | -0.30 |
ESS Tech | GWH | Nov 26, 2024 | 5.97 | +2.05 |
ESSA Bancorp | ESSA | Nov 26, 2024 | 20.19 | -1.56 |
ESSA Pharma | EPIX | Nov 26, 2024 | 1.81 | +0.56 |
Essent Group | ESNT | Nov 26, 2024 | 57.75 | -0.64 |
Essential Properties Realty Trust | EPRT | Nov 26, 2024 | 33.96 | +0.41 |
Essential Utilities | WTRG | Nov 26, 2024 | 40.04 | -0.17 |
Essex Property Trust | ESS | Nov 26, 2024 | 309.75 | +0.05 |
Establishment Labs | ESTA | Nov 26, 2024 | 45.57 | +0.04 |
Estee Lauder Companies | EL | Nov 26, 2024 | 73.18 | +0.29 |
Estrella Immunopharma | ESLA | Nov 26, 2024 | 1.01 | +1.00 |
Eterna Therapeutics | ERNA | Nov 26, 2024 | 0.47 | -8.93 |
ETFMG Alternative Harvest ETF | MJ | Nov 26, 2024 | 2.60 | -0.38 |
Ethan Allen Interiors | ETD | Nov 26, 2024 | 30.51 | -1.71 |
Eton Pharmaceuticals | ETON | Nov 26, 2024 | 12.45 | +3.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.